The global catheter-directed thrombolysis market is valued at USD 454.8 million in 2023. The market is likely to grow at a CAGR of 5.9% and is anticipated to be valued at USD 808 million by 2033.
The demand for catheter-directed thrombolysis is anticipated to increase as the treatment makes use of processes that remove the clot be it based on thrombosis or embolization, the low time duration of treatment, and many other factors. This process is one of the most important preferred methods to treat stroke and related health issues.
| Report Attributes | Details |
|---|---|
| Catheter-Directed Thrombolysis Market Value (2023) | USD 454.8 million |
| Catheter-Directed Thrombolysis Market Anticipated Value (2033) | USD 808 million |
| Catheter-Directed Thrombolysis Market Projected Growth Rate (2023 to 2033) | 5.9% |
Even if we compare the historical CAGR with the anticipated CAGR of the forecast period, there is a positive indication for the market. The historical CAGR of the catheter-directed thrombolysis industry from 2018 to 2022 was 4.9%, while the anticipated CAGR is 5.9%. The good thing is that the market is progressing because of the number of benefits catheter-directed thrombolytic therapy offers.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The seamlessness that this process offers is almost unmatchable. The entire process is done under the purview of X-ray imaging to get the correct site of the clot. Moreover, the technique is used for several treatments, which include thrombosis in the vascular bed, deep vein thrombosis, and thrombosis of dialysis fistulate. This is expected to increase the adoption of catheter-directed thrombolysis and makes the entire process an essential form of stroke medication.
Additionally, on comparing with the traditional heart surgery process, the process is extremely safe, and the duration for which the patient is admitted to the hospital is less. Besides that, based on the stats provided by WHO, it was found that around 17.9 million people died from heart disease in 2019, accounting for 32% of global deaths. This is something that has captured the attention of investors in the catheter-directed thrombolysis industry, as these are mainly used for treating heart diseases.
Furthermore, the availability of emergency medical services and favorable health insurance coverage will also fuel the catheter-directed thrombolysis industry. All these are anticipated to have a positive impact on the catheter-directed thrombolysis market trends and forecasts. However, the application of an IV line to administer anesthesia might lead to certain injuries to the skin. This can be a cause of concern for the catheter-directed thrombolysis industry.
The amazing ability to keep real-time track of the movements inside the body part has been made possible because of fluoroscopy. The application of fluoroscopy has been perceived as a life-saving surgical treatment. Apart from showing the real-time view, this method also helps medical practitioners to place the catheters inside the body with precision.
Moreover, fluoroscopy is used in a wide variety of examinations like Barium x-rays, placement of stents, and orthopedic surgery to carry out a variety of treatments which include viewing the gastrointestinal tract, visualizing blood vessels, guiding joint replacements, etc. Thus, from the above, it can be inferred that the usage of fluoroscopy is likely to increase the scope of the catheter-directed thrombolysis industry.
Principal Consultant
| Attributes | Details |
|---|---|
| Replacing X-rays with Ultrasounds | Continuous exposure to X-rays can lead to health complications. Instead of this, the manufacturers can look for ways to replace X-rays with ultrasound, as these can be applied to any kind of patient, even pregnant women. Moreover, there are no side effects associated with the usage of ultrasounds, and the image quality provided by the usage of ultrasounds is also good. Thus, the replacement of X-rays with ultrasound might very well improve the catheter-directed thrombolysis industry outlook. |
| Replacing the IV method with other methods | Instead of applying an invasive technique to administer anesthesia, the administration can be done through other methods, like administering it in the form of a gas, topical liquid, or any injection. The problem associated with intravenous medication is that it can lead to infection and damage the site of veins and may also lead to air embolism. However, replacing the IV line with anesthesia through gas, topical liquid, or injection is expected to avoid any instances of developing a skin infection or any other kind of complication as these are not pierced into the skin, thereby making the process fully non-invasive, except for the case of injection. The application of any one of these methods can be a positive step for the catheter-directed thrombolysis market. |
| Attributes | Details |
|---|---|
| North America | North America is expected to dominate the catheter-directed thrombolysis industry share due to easy access to advanced healthcare facilities. According to Future Market Insights, the North American catheter-directed thrombolysis market has a market share of 53.4% and is expected to grow at a rapid pace during the forecast period. Moreover, the region is meant for rapid technological advances. According to World Health Organization (WHO), approximately 900,000 people were diagnosed with pulmonary embolism and deep vein thrombosis in the USA. in 2015. Among all end users, the hospital segment dominates the market for catheter-directed thrombolysis over the forecast period. The majority of cases of pulmonary embolism and deep vein thrombosis are treated in hospitals. |
| Europe | Europe is considered to be the 2nd largest market for catheter-directed thrombolysis owing to the presence of a robust reimbursement scenario and improved regulatory framework. According to Future Market Insights, the region has a market share of 24.1% and is expected to grow significantly during the forecast period. Catheter-directed thrombolysis (CDT) with assisted mechanical thrombolysis in the region is considered the standard form of treatment. Deep vein thrombosis (DVT) is the third most common cardiovascular pathology after coronary artery disease and stroke in the region. Due to the growing geriatric population and risk factors that include oral contraceptives, the demand for catheter-directed thrombolysis is expected to increase during the forecast period in Europe. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Start-ups are developing new products with their unique ideas to solve several problems, especially in medical fields for patients. Start-ups in the catheter-directed thrombolysis industry are making new devices that help to prevent cardiovascular disease. Some of the start-ups are:
Corvus Medical:
Corveus Medical is a US-based start-up company that has developed a new device to prevent heart failure in recent years. The innovative device developed by a company named “neuromodulation device” helps to access heart tissues uniquely and safely.
Moray Medical:
Moray Medical is another US-based start-up that improves leaky heart valves by providing microfluidic robotic methods. The start-up treats its patients safely with cost-effective therapies.
The market is consolidated by the prominent vendors present all around the region in recent years. They are using several marketing tactics to acquire lion’s share and are anticipated to grow the catheter-directed thrombolysis market share during the forecast period.
Some of the marketing methodologies adopted by key players are partnerships, acquisitions, mergers, product launches, and collaborations among others. Global players such as Angio Dynamics, Inc. and Boston Scientific Corporation account for a considerable market size. Several regional-level players are also operating across key growth regions.
Recent Developments in the Catheter-Directed Thrombolysis Market:
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 5.9% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Delivery Mode, Indication, End User, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
| Key Countries Profiled | The United States, Canada, Brazil, Argentina, Germany, The United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | AngioDynamics Inc.; Boston Scientific Corporation; iVascular SLU; Straub Medical AG |
| Customization | Available Upon Request |
The market is valued at USD 454.8 million by 2023.
The market is predicted to reach a size of USD 808 million by 2033.
United States to hold sizeable share in the market.
A CAGR of 5.9% is predicted for the market by 2033.
From 2018 to 2022, the market registered a CAGR of 4.9%.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Delivery Mode 5.1. Direct Delivery to Blood Clot Catheter-directed Thrombolysis 5.2. by Positioning Medical Device at Clot Site 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Pulmonary Embolism (PE) 6.2. Deep Vein Thrombosis (DVT) 6.3. Strokes 6.4. Other Indications 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Hospitals 7.2. Surgical Centers 7.3. Radiology Clinics 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. AngioDynamics Inc. 18.2. Boston Scientific Corporation 18.3. iVascular SLU 18.4. Straub Medical AG 18.5. Thrombolex Inc. 18.6. Teleflex Incorporated 18.7. Straub Medical AG 18.8. Penumbra, Inc. 18.9. Medtronic Plc 18.10. Inari Medical, Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Catheter-Directed Thrombolysis Market
